Lantern Pharma Inc. · NASDAQ:LTRN
Thomas A. Satterfield, Jr. reported a 7.60% stake in Lantern Pharma Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 23, 2026
Thomas A. Satterfield, Jr. reported a 7.60% stake in Lantern Pharma Inc., 975,000 shares, as a passive investor on Jun 30, 2026. Filed Jul 23, 2026 (Schedule 13G/A).
- Stake
- 7.60%
- Shares
- 975,000
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Thomas A. Satterfield, Jr. | 7.60% | 975,000 |
Source
Related
- Lantern Pharma Inc.
- Thomas A. Satterfield, Jr.
- Lantern Pharma Inc. shareholders
- Schedule 13G · Thomas A. Satterfield, Jr. · Apr 3, 2026
- Schedule 13G/A · Empery Asset Management, LP · Oct 13, 2026
- Schedule 13G · Empery Asset Management, LP · Aug 4, 2026
- Schedule 13D/A · BIOS Advisors GP, LLC · May 15, 2026
- Form 4 · Schalop Lee Troy · May 14, 2026
- Form 4 · Keyser D Jeffrey · May 14, 2026